Stigmitizing Individuals With Illnesses Can Lead to All of the Following Except:

  • Correspondence
  • Open Access
  • Published:

The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform inquiry, intervention development, and policy on health-related stigmas

  • 78k Accesses

  • 210 Citations

  • 51 Altmetric

  • Metrics details

Abstract

Stigma is a well-documented barrier to wellness seeking beliefs, date in care and adherence to treatment across a range of wellness conditions globally. In order to halt the stigmatization process and mitigate the harmful consequences of health-related stigma (i.e. stigma associated with health conditions), it is critical to accept an explicit theoretical framework to guide intervention evolution, measurement, inquiry, and policy. Existing stigma frameworks typically focus on 1 health condition in isolation and often concentrate on the psychological pathways occurring amongst individuals. This tendency has encouraged a siloed approach to enquiry on health-related stigmas, focusing on individuals, impeding both comparisons across stigmatized conditions and research on innovations to reduce health-related stigma and improve health outcomes. We propose the Health Stigma and Discrimination Framework, which is a global, crosscutting framework based on theory, research, and practice, and demonstrate its application to a range of wellness conditions, including leprosy, epilepsy, mental health, cancer, HIV, and obesity/overweight. We also hash out how stigma related to race, gender, sexual orientation, class, and occupation intersects with health-related stigmas, and examine how the framework can be used to enhance inquiry, programming, and policy efforts. Research and interventions inspired past a common framework will enable the field to identify similarities and differences in stigma processes across diseases and will amplify our collective power to answer effectively and at-calibration to a major driver of poor health outcomes globally.

Peer Review reports

Background

Stigma is a well-documented global barrier to health-seeking behavior [ane], appointment in intendance [ii], and adherence to handling [3] beyond a range of health weather condition [4, 5]. As a distinguished and labelled departure [6], stigma, Goffman notes, enables varieties of discrimination that ultimately deny the individual/group full social acceptance, reduce the individuals' opportunities [7], and fuel social inequalities [eight]. Stigma influences population health outcomes past worsening, undermining, or impeding a number of processes, including social relationships, resource availability, stress, and psychological and behavioral responses, exacerbating poor health [ix].

In order to intervene to halt the stigmatization process or mitigate the harmful consequences of wellness-related stigma, or stigma associated with health atmospheric condition, the existence of a clear, multi-level theoretical framework to guide intervention development, measurement, inquiry, and policy is critical. Existing stigma frameworks typically focus on i health condition in isolation, for example, obesity/overweight [10,11,12,13,14,15,xvi,17], HIV [eight, eighteen,19,xx,21,22,23], or mental health [24,25,26,27,28]. This tendency has encouraged a siloed approach to enquiry on health-related stigmas, stifling innovative public health responses. Alderson argues that it is practical and scientific to examine theories, every bit they powerfully influence how bear witness is nerveless, analysed, understood and used and notes that, when theories are implicit, their power to clarify or to misfile, and to reveal or obscure new insights, tin can work unnoticed [29]. As such, it is useful to take an explicit theoretical framework that can both guide research and intervention development on private wellness conditions and let for comparisons and responses beyond health conditions.

The majority of health-related stigma frameworks explore psychological pathways at the individual level, focusing either on the individuals experiencing stigma [10, 11, 14,15,sixteen, 30, 31], those perpetuating stigma [21, 26], or both [20, 24, 32]. While disquisitional to understanding the factors that facilitate and mediate the stigmatization process for individuals, these frameworks limit researchers' ability to inform the multi-level interventions required to meaningfully influence the stigmatization procedure [33]. For some health conditions, including HIV [8, 18, 19, 23, 34, 35], mental wellness [27, 28], kid health [35], and obesity/overweight [17], frameworks addressing the social (e.chiliad. cultural and gender norms) and structural (e.m. legal surroundings and health policy) pathways leading to stigma, in addition to the individual pathways, take been proposed. A few general stigma frameworks have as well highlighted the influence of social and structural forces on the stigmatization process across socio-ecological levels [6, nine, 36]. In the context of wellness-related stigma reduction, socio-ecological levels have been divers as public policy (national and local laws and policies), organizational (organizations, social institutions, workplaces), community (cultural values, norms, attitudes), interpersonal (family unit, friends, social networks), and individual (knowledge, attitudes, skills) [37].

Building from existing conceptualizations of wellness-related stigmas and applied experience in designing stigma-reduction interventions, we propose a new, crosscutting framework and demonstrate its application to a range of health conditions, including leprosy, epilepsy, mental health, cancer, HIV, and obesity/overweight. We discuss how stigma related to race, gender, sexual orientation, class, and occupation intersects with health-related stigmas, and examine how the framework can be used to enhance research, programming, and policy efforts. The framework is intended to amplify our collective ability to respond effectively and at-scale to a major commuter of poor health outcomes globally.

The Wellness Stigma and Discrimination Framework

The Health Stigma and Discrimination Framework (Fig. i) articulates the stigmatization process equally it unfolds across the socio-ecological spectrum in the context of health, which tin vary across economic contexts in low-, centre-, and high-income countries. The process can be broken downward into a series of constituent domains, including drivers and facilitators, stigma 'marking', and stigma manifestations, which influence a range of outcomes among affected populations, also as organizations and institutions, that ultimately bear upon wellness and lodge.

Fig. 1
figure 1

Health Stigma and Discrimination Framework

Full size paradigm

The first domain refers to factors that bulldoze or facilitate health-related stigma. Drivers vary by health condition, just are conceptualized equally inherently negative [xviii]. They may range from fright of infection through coincidental contact for communicable diseases and concerns nigh productivity due to poor health for chronic conditions, to absolutism and social judgment and blame. Conversely, facilitators may be positive or negative influences [33], for case, the presence or absence of occupational safety standards and protective supplies in health facilities can minimize or exacerbate stigmatizing avoidance behaviors towards populations with infectious diseases past healthcare workers [38]. Drivers and facilitators decide whether stigma 'marking' occurs, through which a stigma is applied to people or groups according to a specific health condition or other perceived deviation such as race, class, gender, sexual orientation, or occupation. Intersecting stigma occurs when people are 'marked' with multiple stigmas [39]. In one case a stigma is practical, information technology manifests in a range of stigma experiences (i.e. lived realities) and practices (i.due east. beliefs, attitudes, and actions). Stigma experiences tin include experienced discrimination, which refers to stigmatizing behaviors that fall inside the purview of the constabulary in some places, such as refusal of housing [33], and experienced stigma, or stigmatizing behaviors that fall exterior the purview of the law such as verbal abuse or gossip [33]. The legal distinction is included as responding to a stigma manifestation that is illegal may require a unlike response (e.thousand. litigation) compared with a manifestation that is not illegal. Another stigma experience is internalized or 'cocky-stigma', which is defined as a stigmatized grouping fellow member'south own adoption of negative societal beliefs and feelings, equally well as the social devaluation, associated with their stigmatized status [forty]. Perceived stigma (i.e. perceptions about how stigmatized groups are treated in a given context) [41] and anticipated stigma (i.e. expectations of bias being perpetrated by others if their health condition becomes known) are also classified as stigma experiences [42]. Finally, secondary or 'associative' stigma, which refers to the feel of stigma by family or friends of members of stigmatized groups or amidst healthcare providers who provide care to members of stigmatized groups [43], is included under stigma experiences. Stigma practices tin can include stereotypes (i.e. behavior about characteristics associated with the group and its members), prejudice (i.e. negative evaluation of the grouping and its members), stigmatizing behavior (i.e. exclusion from social events, avoidance behaviors, gossip), and discriminatory attitudes (i.due east. belief that people with a specific wellness status should not be allowed to participate fully in society). Nosotros included stereotypes and prejudice under 'drivers' and 'manifestations', as they both fuel and are reinforced by the stigmatization process.

We postulate that stigma manifestations subsequently influence a number of outcomes for afflicted populations, including access to justice, access to and acceptability of healthcare services, uptake of testing, adherence to treatment, resilience (i.e. the ability to challenge stigma) [34, 44], and advocacy. They likewise influence outcomes for organizations and institutions, including laws and policies, the availability and quality of health services, law enforcement practices, and social protections.

While the framework is specific to wellness-related stigma, it recognizes that wellness-related stigma oft co-occurs with other, intersecting stigmas, such as those related to sexual orientation, gender, race, occupation, and poverty. Therefore, incorporating intersecting stigmas into the framework is necessary, every bit stigma manifestations and wellness outcomes may exist influenced by a range of stigmatizing circumstances that must be considered to empathize the total impact of stigma [v, 36].

How is the framework unlike?

The Wellness Stigma and Bigotry Framework differs from many other models in that it does not distinguish the 'stigmatized' from the 'stigmatizer' [21, 32]. The absence of this dichotomy is intentional, equally nosotros seek to challenge the 'us' versus 'them' distinction that enables people to prepare others apart as 'different from the norm', a key component of the stigmatization process described past Link and Phelan [6], which precedes stigma 'marking'. As suggested past Parker and Aggleton [eight], we seek to motion abroad from psychological models that see stigma as a matter which individuals impose on others and instead emphasize, the broader social, cultural, political and economical forces that structure stigma.

According to Kippax et al. [45], the danger in separating 'us' from 'them', or 'agency' from 'vulnerability', is that it removes the power that vulnerable populations have to human action upon the social contexts driving their experiences, behaviors, and actions. The dichotomy also leads to an oversimplified view of vulnerable populations every bit a group of individuals defined and connected only by the 'attribute' of vulnerability [45]. Our framework seeks to bear witness the interconnections between power and vulnerability and how they are fluid and circuitous. We want to underscore that all individuals can conceptualize, perceive, internalize, feel, or perpetuate wellness-related stigma, while acknowledging unique outcomes for affected populations. There are no articulate-cutting boundaries nearly who experiences and who perpetuates stigma, withal, as nosotros highlight throughout each example, stigma intersects with other axes of disempowerment and marginalization (e.g. across race, class, gender) in ways that result in some persons existence more disadvantaged by health-related stigma. Removing the 'us' versus 'them' dichotomy also makes the framework more palatable to change agents, such as community leaders, advocates, and policy-makers, as information technology highlights that all persons can act every bit change agents and underscores the need for self-reflection and sensation of biases.

Some other difference from previous frameworks is the separation of manifestations into 'experiences' and 'practices'. This stardom clarifies the pathways to diverse outcomes following the stigma-mark phase of the process. Those who experience, internalize, perceive, or anticipate health-related stigma face a range of possible outcomes, such equally delayed treatment, poor adherence to treatment, or intensification of take a chance behavior, that may diminish their health and wellbeing. While outcomes are mostly negative, positive outcomes are possible; stigma has been known to foster resilience in marginalized populations [46] and fuel the germination of patient advocacy groups and advancement efforts that have led to major policy changes to improve access to healthcare for some stigmatized conditions like HIV [36, 47]. Stigma practices, on the other hand, highlight how the stigmatization process tin can generate or reinforce stereotypes and prejudice towards people or groups living with or at take chances of diverse health conditions and foster discriminatory attitudes that fuel social inequalities [8].

Nosotros also differentiated outcomes for affected populations (i.e. the stigmatized person or group, every bit well every bit their family unit, friends, or healthcare providers) from outcomes for organizations and institutions. Our framework seeks to demonstrate that stigma experiences and practices influence affected populations as well as organizations and institutions, which then together influence the health and social impacts of stigma. Past articulating these outcomes, the framework highlights the need for multilevel interventions to answer to health-related stigma. Information technology also focuses attention on the far-reaching influence of health-related stigma on societies too every bit individuals.

Where to intervene?

Ideally, we desire to interrupt the process prior to the application of stigma. Thus, interventions frequently target the removal of the drivers of stigma or the shifting of norms and policies that facilitate the stigmatization procedure [33]. Even so, once a stigma is practical to people with a specific disease or wellness condition and once it manifests in experiences or practices, interventions are needed to mitigate damage and shift harmful attitudes and behaviors that compromise the general wellness and wellbeing of affected communities. Stigma-reduction interventions are virtually effective when they include components directed at a range of actors and socio-ecological levels [37]. A multi-component intervention, for instance, may seek to support individuals with leprosy to cope with experienced stigma and overcome internalized stigma, likewise as reaching out to community members to shift harmful norms almost leprosy through community dialogues or engaging local leaders to share anti-stigma letters [48]. Likewise, advocacy with policy-makers and community leaders about the benefits of syringe exchange programs to preclude transmission of HIV may be combined with training of law enforcement officers on harm reduction and proper implementation of laws that de-criminalize drug use [49].

What to monitor?

The availability of data on health-related stigma and discrimination is critical for improving interventions and programs to address them, yet such routine data are frequently defective [33]. The Health Stigma and Discrimination Framework indicates cardinal areas of focus for program-, facility-, and national-level monitoring. At the programme level, information on the drivers and facilitators of stigma are needed to inform appropriate interventions in a given context. Systematically collected information regarding the manifestations of stigma is required for researchers and programme evaluators to appraise the touch on of interventions to reduce stigma or mitigate the related harmful consequences. Such data is besides important for wellness facility administrators to identify when training or changes to institutional policies are required to ensure a stigma-complimentary healthcare environment. Affected communities and advocates tin can use information on stigmatizing practices, too as the experiences and realities of affected individuals, to enhance awareness amongst the full general population and policy-makers to facilitate change. At the national level, data on the outcomes of stigma for afflicted populations and for organizations and institutions is needed to inform funding for and the calibration of programming to address health-related stigma. Such data will also aid to identify gaps where new interventions or programs are required.

Why a new framework and how to use it?

Since sociologist Erving Goffman published his seminal work on stigma in 1963, research on stigma across the disciplines of sociology, psychology, social science, medicine, and public wellness have expanded, and much is now understood almost how stigma operates and induces harm in the context of different diseases and identities. Yet, progress has stalled in our collective power to tackle stigma and its harmful consequences. Therefore, cross-disciplinary and cross-disease inquiry and collaboration are urgently required to movement forward.

The Wellness Stigma and Discrimination Framework is intended to be a broad, orienting framework, akin to Pearlin'due south Stress Process Model, which was developed to give some conceptual organization to the diverse lines of research that were – and still are – underway [50]. It is our hope that the framework volition enable stigma researchers across disciplines to standardize measures, compare outcomes and build more effective, cross-cut interventions. In addition, researchers can use the framework to generate research foci, to explore multiple health bug, and consider the interaction between multiple identities, social inequalities and wellness issues. The framework tin also point to areas where clinicians, program implementers, and policy-makers can focus greater attention to better see the needs of and amend health outcomes amidst their clients, communities, and societies more than broadly. Implementation science approaches tin can accelerate how we tailor and apply the framework to guide stigma and discrimination reduction interventions and policies, for case, in defining the target audition for alter, what specific drivers and facilitators of stigma should be addressed, what intervention or policy components are appropriate to accost them, and how to measure change in specific outcomes overtime.

Practical applications

To demonstrate the cross-cutting nature of the Health Stigma and Discrimination Framework, we examine how it applies to both catching and non-communicable wellness weather condition. We review wellness conditions in roughly chronological order to provide perspective on how wellness-related stigma has been applied to new and emerging atmospheric condition throughout the course of human history. While the different domains of stigma articulated in the framework may not employ in the exact same way across all wellness conditions, wellness-related stigmas share a number of commonalities that warrant underscoring.

Firstly, social exclusion rooted in stigma appears to exist a response to threat, varying across health-related stigma to the degree to which the source of threat is concrete (such as fear of biological contamination, fear of violence and harm) or symbolic (such as aversion based on perceptions that the person does not adhere to key cultural values). Beyond the various health-related stigmas, people negatively stereotype, display prejudice toward, and discriminate the grouping and its members, although the content of the stereotype (e.g. being promiscuous, unclean) and the rationalization for the bias differ beyond the groups. In add-on, these conditions differ in the extent to which they are concealable and thus in the mode people cope with and manage their stigmatized identity, but all involve anticipated, experienced, and internalized stigma. Finally, how people cope with and manage stigma often adversely affects their health, both in terms of the stress it causes and in the underutilization of services available to them. Tabular array 1 highlights both the commonalties and differences in drivers, facilitators, intersecting stigmas, manifestations, outcomes, and impacts relevant to leprosy, epilepsy, mental health, cancer, HIV, and obesity/overweight, which are further explored beneath.

Table 1 Illustrative examples of how the Health Stigma and Discrimination Framework can be applied to dissimilar health conditions

Full size table

Leprosy

Leprosy is perhaps the oldest stigmatized health status known to humankind [51]. Most major religious scriptures brand mention of leprosy, often as a condition to be avoided and/or as a divine supernatural penalty for sin or breaking a taboo [52]. The notion that leprosy – or a grouping of skin diseases that included leprosy – was contagious was already nowadays in the Old Testament of the Bible. Fear of contamination and social exclusion remains closely tied to the prototype of leprosy [53,54,55] and the belief that leprosy is hereditary is also widespread [54, 56]. Together, these factors drive the stigmatization process for people living with leprosy.

The fact that persons affected by leprosy often have a low socioeconomic status, a low level of education and little sensation of human rights increases people's vulnerability to discrimination [57]. In South Asia, a low-caste background can add a farther, intersecting layer of stigma, as is the case for women in many endemic countries [58]. The stigma attached to leprosy typically manifests as a 'spoiled identity' in the affected person, affecting condition and reputation, including that of family unit members [54, 59]. Social participation may be severely restricted, including problems in finding or maintaining a job, reduced access to education, reduced opportunities in finding a marital partner or problems in ongoing marriages, and sexual health [52, threescore,61,62].

Further, many persons affected seek to conceal their condition [63, 64]. Concealment causes stress and anxiety, but may besides atomic number 82 to a filibuster in presenting for diagnosis and treatment [65, 66]. When treatment is delayed, the severity of disability may increase [67, 68]. Others may opt to discontinue handling rather than take a chance 'beingness found out' [64]. At the personal level, these outcomes of stigma lead to a number of negative impacts for people living with leprosy, such equally reduced quality of life and mental wellbeing, including a much increased risk of feet and low [69, 70]. At the organizational level, leprosy-related stigma outcomes may include poor quality of health services and increased staff turnover. At the societal level, the combined impact of these outcomes may be prolonged transmission of bacilli in the community.

Epilepsy

Epilepsy is a neurological condition characterized by chronic or recurrent seizures. Seizures can atomic number 82 to individuals crying out, collapsing, bleeding or foaming from the oral cavity, and losing control of urine and/or stools, and tin therefore be frightening to those experiencing or witnessing them. Epilepsy is both concealable and unpredictable – it may exist impossible to know that someone has epilepsy until they experience a seizure and it may be impossible to predict the onset of a seizure. Epilepsy-related stigma is largely driven by concerns virtually productivity and longevity, and fear of infection. Members of the general public endorse behavior that people with epilepsy cannot contribute meaningfully to society and are poor prospects for marriage and employment [71,72,73]. Moreover, despite epilepsy not beingness contagious, some believe that epilepsy is contagious through saliva [74]. Such fears of contagion may be particularly problematic when they are endorsed by start responders, including police officers [75].

Religious and supernatural beliefs act as facilitators of epilepsy-related stigma in some contexts, with some believing that epilepsy is a curse or caused by witchcraft [76]. Risk factors for epilepsy include other health issues (e.1000. cognitive palsy, birth asphyxia, stroke) and injuries (e.grand. traumatic brain injury), and therefore epilepsy-related stigma may intersect with these other health-related stigmas. People with epilepsy experience a number of manifestations, such as social rejection and exclusion in a range of contexts, including familial and romantic [77]. Children with epilepsy have lower educational achievement and adults with epilepsy experience discrimination within the workplace [76]. Adults with uncontrolled seizures are less likely to be employed and more than likely to study job problems when employed [77]. Outcomes of epilepsy-related stigma include lower cocky-efficacy surrounding treatment engagement and lower medication adherence [4]. Institutional outcomes include stigmatizing policies such as driving and/or employment restrictions that may be asymmetric to affliction severity [78]. Epilepsy-related stigma ultimately undermines the quality of life of people living with epilepsy [72].

Mental health

Mental health-related stigma is often grounded in stereotypes that persons with mental health issues are dangerous (unpredictable, vehement), responsible for their mental health issue, cannot be controlled nor recover, and should be aback [79]. Persons with mental health problems are often viewed as incompetent and unable to work or live independently [79]. Negative public attitudes, opinions, and intentions persist and are reported beyond diverse global contexts [eighty,81,82,83]. For instance, findings from the Stigma in Global Context – Mental Health Study, examining responses to scenarios of depression and schizophrenia in 16 countries [84], indicated that core 'courage' stigmatizing beliefs remain across settings with regards to having a person with mental health bug provide childcare, teach children, marry into the family, attempt self-harm, or agree potency positions.

Race and gender announced to intersect with mental health-related stigma, influencing its severity. For example, a higher risk for psychiatric disorders among Caribbean-born versus US-built-in black men has been reported [85] and greater embarrassment in seeking mental health intendance has been reported amid Somalian-born participants compared to US-built-in blackness participants [86]. Sure mental health concerns are perceived equally masculine (e.g. habit, antisocial personality disorder) and others every bit feminine (e.g. eating disorder), and public stigma towards issues perceived as masculine appears to be higher than towards those perceived as feminine [87, 88]. There are also gender differences in perceived stigma, where men may experience elevated stress regarding disclosing mental wellness issues in comparison to women [89]. Anticipated and perceived stigma are common manifestations of mental health-related stigma, contributing to fear of acknowledging one'south mental wellness upshot and possibly leading to shame and avoidance regarding seeking mental health care [xc, 91]. Mental health-related stigma also has a profound influence on life opportunities and persons realizing their goals and potential; information technology is associated with lower self-efficacy and cocky-esteem and compromised engagement in employment and contained living [92].

Public policy responses in some countries take gone a long way towards reducing or ameliorating the harmful effects of mental health-related stigma at the organizational and institutional levels. For case, in the Usa, the Americans with Disabilities Act [93] enacted in 1990 called for preventing bigotry on the basis of mental health and for the social inclusion and participation of persons with mental health problems in society. In 1999, this was followed by Mental Health: A Report of the Surgeon Full general [94] to inform the public of mental health problems and raise awareness of stigma and discrimination. Additionally, California's Mental Health Services Human activity in 2004 [95] addressed stigma at institutional, societal and private levels, including social marketing, training, and a focus on cultural competence.

Cancer

Cancer encompasses a large group of diseases characterized by the uncontrolled growth and spread of abnormal cells. Despite the fact that many cancers tin can exist cured or at least effectively controlled, it remains a highly stigmatized condition, with some types of cancer more stigmatized than others [96]. One key cistron in the stigmatization of different types of cancer involves perceptions of the individual's responsibility for having the disease. For example, cancers of the lung are highly stigmatized [ane] due to the belief that smoking is their principal cause, which is believed to exist under the person's control [97]. Most people have negative explicit and implicit attitudes toward smoking and those who fume [98], which may farther strengthen the stigmatization of people with lung cancer. A 2d cistron underlying cancer-related stigma is the degree to which the disease causes credible disfigurement such as cancers of the throat or rima oris. As with other physical conditions, such as weight loss/gain or leprosy, the physical abnormalities associated with some forms of cancer activate the behavioral immune organisation, eliciting negative emotions such as cloy or disfavor, distancing, and avoidance [99].

The feel of cancer-related stigma has of import psychological, concrete, and social consequences. Psychologically, it is associated with depression, anxiety, and demoralization among patients with cancer [100]. Individuals who experience greater cancer-related stigma tend to delay more in seeking medical care [101] and often endeavour to muffle their disease from others [102]. To the extent to which people experience stigma and shame associated with their disease, such as is common with people with lung cancer, they often experience disruption in their personal relationships and decreased marital satisfaction, besides equally increased low, peculiarly when they blame themselves for their illness [103]. Greater internalization of cancer-related stigma leads to lower self-esteem and poorer mental health, smaller social networks and less opportunity to receive social back up, and greater anticipated social rejection, all of which compromise the quality of life [104].

The stigma associated with cancer varies across religions and related cultures. Although women who are members of ultra-Orthodox Jewish communities are at heightened risk for both chest and ovarian cancer due to an increased probability of beingness carriers of certain genes associated with these cancers given their Eastern and Central European ancestry, they tend to take low screening rates, low health literacy, and poor wellness practices because of the stigmatization of cancer in these communities [105]. Fears that a diagnosis of chest cancer will dim prospects for arranged marriages have been shown to discourage unmarried Muslim women from accessing treatment for breast cancer in Pakistan [106]. Similarly, South Asian immigrant women of many dissimilar faiths in Canada share the belief that having a chest cancer diagnosis would threaten a family's social status and lead to spousal rejection [106].

HIV

HIV is a potentially life-threatening affliction acquired by a virus that weakens the immune organization and spreads through blood and sexual contact. HIV-related stigma is driven past several factors, including (i) fear of infection, where people living with HIV (PLHIV) may exist perceived as threatening due to the infectious nature of HIV; (two) concerns near productivity and longevity, where PLHIV may be perceived as poor prospects for employment, friendships, and romantic relationships; and (3) social norm enforcement, since HIV run a risk is related to a range of socially stigmatized behaviors (e.g. aforementioned-sex sexual relations, injection drug apply, sex work) and therefore PLHIV are devalued due to their perceived associations with these behaviors [107, 108]. Factors that facilitate HIV stigma range from laws that criminalize HIV transmission or specific professions (e.k. sexual activity work) or behaviors (eastward.yard. same-sex sexual relations, injection drug utilize) to the lack of universal protection supplies in health facilities. Cardinal populations for HIV include men who have sex activity with men, people with histories of injection drug use, racial and ethnic minorities, and sexual activity workers, and therefore stigmas that intersect with HIV include those associated with sexual orientation, substance use, race, and occupation [36, 109].

PLHIV, including adolescents and young people, report a range of stigmatizing experiences from others, including social rejection, exclusion, gossip, and poor healthcare, and are at adventure of internalizing stigma [110]. The level of HIV stigma in communities and societies influences a number of stigma practices, such as discriminatory attitudes amongst the general public and healthcare workers, and harmful stereotypes and prejudices that can lead to stigmatizing behavior towards PLHIV (exclusion, exact abuse, etc.). Outcomes of HIV stigma for people at risk of or living with HIV include engagement in greater HIV risk behaviors, lower rates of HIV testing, worse appointment and retentiveness in HIV care, and worse initiation and adherence to medication [iii, 44, 111]. Institutional outcomes include stigmatizing policies such equally those that criminalize PLHIV who practise not disclose their HIV condition to their partners or prohibit PLHIV from traveling. Finally, HIV-related stigma has downstream effects on HIV incidence too as morbidity, mortality, and quality of life for PLHIV [3, 109].

Overweight and obesity

The stigma associated with weight is peculiarly strong, pervasive, and openly expressed. There seem to be minimal social norms prohibiting weight shaming, making it particularly problematic. Information technology develops relatively early in socialization, emerging every bit early as 31 months [112]. Obesity and overweight are ofttimes perceived as culturally non-normative, and therefore people with obesity or overweight are often perceived unfavorably, negatively stereotyped, and discriminated against. Additionally, since weight is generally perceived every bit personally controllable, overweight implies negative personal qualities. Individuals with obesity are often blamed for their weight status and stereotyped equally lazy, lacking willpower, incompetent, and unattractive, particularly in cultures that concord core values, such as the Protestant Work Ethic, that emphasize self-control and hard work [113]. In improver to concerns almost grapheme, considering obesity and overweight are perceived as abnormal physical features, they may activate the behavioral immune system [99] and arm-twist disgust and related concerns about illness avoidance [114], which leads to distancing and other direct forms of social rejection. Weight-based disparities are well documented in employment, healthcare, teaching, and interpersonal outcomes [115, 116].

Experiencing and anticipating weight-based stigma (including bigotry, teasing and bullying, social rejection, and other forms of unfair handling) adversely affects the mental and physical health of people with overweight or obesity [117]. Psychologically, experiencing greater weight-based discrimination is associated with heightened distress (including depression and anxiety) and depression self-esteem generally, too as demoralization and macerated confidence in existence able to pursue health-promoting behaviors. Physically, people who experience greater weight-based stigma display less cardiovascular fitness, muscular force, and endurance [118]. Further, since exposure to weight-based stigma more often than not reduces motivation, intentions, and feelings of efficacy related to engaging in health-promoting behaviors, weight-based stigma has adverse effects on weight management. Consequently, experiencing more weight-based stigmatization predicts greater caloric consumption and reduced free energy expenditure during weight-loss treatment [119]. Thus, weight stigma may contribute to obesity-related health issues due to added stress and reduced date in health-promoting behaviors, which jointly operate to increment or maintain excess weight.

In healthcare settings, women who perceive stigmatization from their providers report delaying use of preventive health services for fright of being judged or embarrassed [120]. This avoidance of care allows for untreated problems to progress to a more avant-garde phase that may exist more hard to treat, thus exacerbating health problems. Moreover, these psychological, physical, motivational, and behavioral effects of weight-based stigma are particularly stiff amidst individuals who internalize this stigma to a greater degree. In terms of responses at the public policy level, there are currently no federal laws against weight-based discrimination; even so, one state (Michigan), and a limited number of cities in the US, legally prohibit weight-based discrimination.

Give-and-take

The Wellness Stigma and Discrimination Framework provides an innovative and culling method to conceptualize and answer to health-related stigmas. Applicable across a range of health weather condition and diseases, the framework highlights the domains and pathways mutual across wellness-related stigmas and suggests key areas for inquiry, intervention, monitoring, and policy. This crosscutting approach will support a more efficient and effective response to addressing a pregnant source of poor health outcomes globally.

The Health Stigma and Bigotry Framework has applied applications for program implementers, policy-makers, and researchers akin, providing a 'mutual footing' to inform soapbox effectually research priorities, developing innovative responses and implementing them at scale. For program implementers, the framework tin inform the combination and level of interventions well-nigh appropriate for responding to a specific type of health-related stigma. For policy-makers, the framework has the potential to lead to efficiencies in funding for and implementation of efforts to reduce health-related stigmas. Lastly, for researchers, the framework should enable more concise and comparable measures of stigma that can exist compared across health conditions and diseases past removing the disease siloes of the past and replacing them with common domains and terminology that is more attainable. The framework should also enable crosscutting research endeavors to develop and test interventions that more appropriately accost the lived realities of vulnerable populations accessing healthcare systems.

People are not defined by just i disease or one perceived deviation, they have complex realities in which to maneuver in order to protect their health and wellbeing, and public health interventions must exist responsive to these realities.

References

  1. Scott N, Crane M, Lafontaine 1000, Seale H, Currow D. Stigma as a barrier to diagnosis of lung cancer: patient and full general practitioner perspectives. Prim Health Care Res Dev. 2015;16(06):618–22.

    Commodity  Google Scholar

  2. Corrigan P. How stigma interferes with mental health care. Am Psychol. 2004;59(7):614–25.

    Article  Google Scholar

  3. Mahajan AP, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forrad. AIDS. 2008;22(Suppl 2):S67–79.

    PubMed Central  Article  PubMed  Google Scholar

  4. DiIorio C, et al. The clan of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav. 2003;iv(iii):259–67.

    Article  Google Scholar

  5. Link B, Hatzenbuehler ML. Stigma equally an Unrecognized Determinant of Population Health: Inquiry and Policy Implications. J Health Polit Policy Law. 2016;41(4):653–73.

    Article  Google Scholar

  6. Link BG, Phelan JC. Conceptualizing Stigma. Annu Rev Sociol. 2001;27(1):363–85.

    Article  Google Scholar

  7. Goffman Due east. Stigma: Notes on the Direction of Spoiled Identity. New York: Simon & Schuster, Inc.; 1963.

    Google Scholar

  8. Parker R, Aggleton P. HIV and AIDS-related stigma and bigotry: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24.

    Article  Google Scholar

  9. Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a Fundamental Crusade of Population Health Inequalities. Am J Public Wellness. 2013;103(5):813–21.

    PubMed Cardinal  Article  PubMed  Google Scholar

  10. Barlösius E, Philipps A. Felt stigma and obesity: Introducing the generalized other. Soc Sci Med. 2015;130:nine–15.

    Article  Google Scholar

  11. Tomiyama AJ. Weight stigma is stressful. A review of prove for the Cyclic Obesity/Weight-Based Stigma model. Appetite. 2014;82:8–15.

    Article  Google Scholar

  12. Abu-Odeh D. Fat stigma and public health: a theoretical framework and ethical assay. Kennedy Inst Ethics J. 2014;24(3):247–65.

    Article  Google Scholar

  13. DeJoy SB, Bittner M. Obesity Stigma equally a Determinant of Poor Birth Outcomes in Women with High BMI: A Conceptual Framework. Matern Kid Wellness J. 2015;19(4):693–9.

    Article  Google Scholar

  14. Sikorski C, Luppa M, Luck T, Riedel-Heller SG. Weight stigma 'gets nether the skin'-evidence for an adapted psychological mediation framework-a systematic review. Obesity. 2015;23(ii):266–76.

    Article  Google Scholar

  15. Ratcliffe D, Ellison N. Obesity and Internalized Weight Stigma: A Conception Model for an Emerging Psychological Problem. Behav Cogn Psychother. 2015;43(02):239–52.

    Article  Google Scholar

  16. Himmelstein MS, Puhl RM, Quinn DM. Intersectionality: An Understudied Framework for Addressing Weight Stigma. Am J Prev Med. 2017;53(iv):421–31.

    Article  Google Scholar

  17. Puhl RM, Heuer CA. Obesity stigma: important considerations for public health. Am J Public Wellness. 2010;100(6):1019–28.

    PubMed Primal  Article  PubMed  Google Scholar

  18. Stangl AL, Brady L, Fritz K. Measuring HIV stigma and discrimination. Washington, D.C.: International Center for Research on Women; 2012.

    Google Scholar

  19. Stangl A, Sievwright M. HIV-Related Stigma and Children. In: A Clinical Guide to Pediatric HIV. Cham: Springer International Publishing; 2016. p. 297–315.

    Affiliate  Google Scholar

  20. Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma machinery measures. AIDS Behav. 2009;13(half-dozen):1160–77.

    PubMed Central  Article  PubMed  Google Scholar

  21. Misir P. Structuration Theory. J Int Assoc Provid AIDS Care. 2015;14(4):328–34.

    Commodity  Google Scholar

  22. Steward WT, et al. HIV-related stigma: Adapting a theoretical framework for use in India. Soc Sci Med. 2008;67(8):1225–35.

    PubMed Central  Commodity  PubMed  Google Scholar

  23. Holzemer WL, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs. 2007;58(half-dozen):541–51.

    Commodity  Google Scholar

  24. Fox AB, Earnshaw VA, Taverna EC, Vogt D. Conceptualizing and measuring mental affliction stigma: The mental affliction stigma framework and critical review of measures. Stigma Heal. 2018;3(4):348–76.

  25. Yang LH, et al. A theoretical and empirical framework for constructing civilisation-specific stigma instruments for Chile. Cad saude coletiva. 2013;21(1):71–9.

    Article  Google Scholar

  26. Longdon E, Read J. 'People with Bug, Not Patients with Illnesses': Using Psychosocial Frameworks to Reduce the Stigma of Psychosis. Isr J Psychiatry Relat Sci. 2017;54(1):24–8.

    Google Scholar

  27. Pescosolido BA, Martin JK, Lang A, Olafsdottir Southward. Rethinking theoretical approaches to stigma: A Framework Integrating Normative Influences on Stigma (FINIS). Soc Sci Med. 2008;67(3):431–forty.

    Article  Google Scholar

  28. Mukolo A, Heflinger CA, Wallston KA. The Stigma of Babyhood Mental Disorders: A Conceptual Framework. J Am Acad Kid Adolesc Psychiatry. 2010;49(2):92–103.

    PubMed Primal  PubMed  Google Scholar

  29. Alderson P. The importance of theories in health care. BMJ. 1998;317(7164):1007–ten.

    CAS  PubMed Central  Commodity  PubMed  Google Scholar

  30. Schabert J, Browne JL, Mosely K, Speight J. Social Stigma in Diabetes. Patient - Patient-Centered Outcomes Res. 2013;6(1):i–ten.

    Article  Google Scholar

  31. Hatzenbuehler ML. How does sexual minority stigma 'get under the peel'? A psychological mediation framework. Psychol Bull. 2009;135(v):707–30.

    PubMed Primal  Article  PubMed  Google Scholar

  32. Weiss MG. Stigma and the Social Burden of Neglected Tropical Diseases. PLoS Negl Trop Dis. 2008;2(5):e237.

    PubMed Primal  Article  PubMed  Google Scholar

  33. Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral Due south. A systematic review of interventions to reduce HIV-related stigma and bigotry from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(Suppl 2):three.

    Google Scholar

  34. Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: moving toward resilience. Am Psychol. 2013;68(four):225–36.

    PubMed Central  Commodity  PubMed  Google Scholar

  35. Nayar US, Stangl AL, De Zalduondo B, Brady LM. Reducing stigma and discrimination to improve child health and survival in low-and heart-income countries: Promising approaches and implications for future inquiry. J Wellness Commun. 2014;19 Suppl 1(sup1):142–63.

  36. Logie CH, James 50, Tharao W, Loutfy MR. HIV, Gender, Race, Sexual Orientation, and Sex Work: A Qualitative Report of Intersectional Stigma Experienced by HIV-Positive Women in Ontario, Canada. PLoS Med. 2011;viii(11):e1001124.

    PubMed Key  Article  PubMed  Google Scholar

  37. Heijnders 1000, Van Der Meij S. The fight confronting stigma: An overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;xi(3):353–63.

    Commodity  Google Scholar

  38. Pulerwitz J, Oanh KTH, Akinwolemiwa D, Ashburn K, Nyblade L. Improving infirmary-based quality of care by reducing HIV-related stigma: evaluation results from Vietnam. AIDS Behav. 2015;19(2):246–56.

    Article  Google Scholar

  39. Hargreaves J, et al. P14.fourteen Intersecting stigmas: a framework for data collection and analysis of stigmas faced past people living with hiv and cardinal populations. Sexual activity Transm Infect. 2015;91(Suppl 2):A203.one–A203.

    Article  Google Scholar

  40. Rao D, et al. Feasibility, acceptability, and preliminary efficacy of the unity workshop: an internalized stigma reduction intervention for African American women living with HIV. AIDS Patient Care STDS. 2012;26(x):614–twenty.

    PubMed Primal  Article  PubMed  Google Scholar

  41. Zelaya CE, Sivaram Due south, Johnson SC, Srikrishnan AK, Suniti S, Celentano DD. Measurement of cocky, experienced, and perceived HIV/AIDS stigma using parallel scales in Chennai, Bharat. AIDS Intendance. 2012;24(vii):846–55.

    Article  Google Scholar

  42. Quinn DM, Chaudoir SR. Living with a concealable stigmatized identity: The affect of anticipated stigma, centrality, salience, and cultural stigma on psychological distress and wellness. J Pers Soc Psychol. 2009;97(iv):634–51.

    PubMed Primal  Article  PubMed  Google Scholar

  43. Holzemer WL, et al. Measuring HIV stigma for PLHAs and nurses over time in five African countries. SAHARA J J Soc Asp HIV/AIDS Res Alliance. 2009;6(ii):76–82.

    Article  Google Scholar

  44. Logie CH, et al. Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Intendance Cascade for Women Living With HIV in Canada. J Acquir Immune Defic Syndr. 2018;77(2):144–53.

    PubMed  PubMed Central  Google Scholar

  45. Kippax S, Stephenson N, Parker RG, Aggleton P. Between private agency and structure in HIV prevention: understanding the middle ground of social practice. Am J Public Health. 2013;103(viii):1367–75.

    PubMed Central  Commodity  PubMed  Google Scholar

  46. Trapence G, et al. From personal survival to public health: community leadership past men who have sexual activity with men in the response to HIV. Lancet. 2012;380(9839):400–10.

    PubMed Central  Article  PubMed  Google Scholar

  47. Kerrigan D, et al. A community empowerment approach to the HIV response among sexual activity workers: effectiveness, challenges, and considerations for implementation and calibration-up. Lancet. 2015;385(9963):172–85.

    PubMed Fundamental  Article  PubMed  Google Scholar

  48. Peters RM, Dadun, Zweekhorst MB, Bunders JF, Irwanto, van Brakel WH. A Cluster-Randomized Controlled Intervention Study to Assess the Effect of a Contact Intervention in Reducing Leprosy-Related Stigma in Indonesia. PLoS Negl Trop Dis. 2015;9(10):e0004003.

    PubMed Primal  Article  PubMed  Google Scholar

  49. Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH. The bear upon of legalizing syringe exchange programs on arrests among injection drug users in California. J Urban Health. 2007;84(iii):423–35.

    PubMed Key  Article  PubMed  Google Scholar

  50. Pearlin Fifty. The Stress Procedure Revisited: Reflections on Concepts and Their Interrelationships. In: Aneshensel C, Phelan J, editors. Handbook of the Sociology of Mental Health. New York: Kluwer Bookish Publishers-Plenum Publishers; 1999. p. 395–415.

    Google Scholar

  51. Jopling WH. Leprosy Stigma. Lepr Rev. 1991;62:0305–7518, one–12.

    Google Scholar

  52. Attempt L. Gendered experiences: wedlock and the stigma of leprosy. Asia Pacific Disabil Rehabil J. 2006;17(two):55–72.

    Google Scholar

  53. de Stigter DH, de Geus L, Heynders ML. Leprosy: between acceptance and segregation. Community behaviour towards persons affected by leprosy in eastern Nepal. Lepr Rev. 2000;71(four):492–8.

    Google Scholar

  54. Engelbrektsson U. Challenged Lives: A Medical Anthropological Study of Leprosy in Nepal. Göteborg: Academy of Gothenburg; 2012.

    Google Scholar

  55. Peters RMH, Dadun, Mimi Lusli, et al. The meaning of leprosy and everyday experiences: An exploration in Cirebon, Indonesia. J Trop Med. 2013;2013(Article ID 507034):10. https://doi.org/10.1155/2013/507034.

  56. Schuller I, et al. The way women feel disabilities and especially disabilities related to leprosy in rural areas in S Sulawesi, Indonesia. Asia Pacific Disabil Rehabil J. 2010;21(1):lx–seventy.

    Google Scholar

  57. Sermrittirong Southward, van Brakel WH. Stigma in leprosy: concepts, causes and determinants. Lepr Rev. 2014;85(ane):36–47.

  58. Dijkstra JIR, van Brakel WH, van Elteren One thousand. Gender and leprosy-related stigma in endemic areas: A systematic review. Lepr Rev. 2017;88:iii.

    Google Scholar

  59. Dako-Gyeke M. Courtesy stigma: A concealed consternation among caregivers of people affected by leprosy. Soc Sci Med. 2018;196:190–vi.

    Article  Google Scholar

  60. van Brakel WH, et al. Disability in people affected by leprosy: the role of impairment, activeness, social participation, stigma and discrimination. Glob Health Action. 2012;five:1–11.

    Google Scholar

  61. van't Noordende AT, van Brakel WH, Banstola N, Dhakal KP. The touch on of leprosy on marital relationships and sexual health among married women in eastern Nepal. J Trop Med. 2016;2016:4230235.

  62. Raju MS, Reddy JVS. Community attitude to divorce in leprosy. Indian J Lepr. 1995;67(4):389–403.

    CAS  Google Scholar

  63. Peters RMH, et al. Narratives around concealment and agency for stigmareduction: A study of women afflicted by leprosy in Cirebon District, Indonesia. Disabil CBR Incl Dev. 2014;25(4):5–21.

    Article  Google Scholar

  64. Heijnders ML. The Dynamics of Stigma in Leprosy. Int J Lepr Other Mycobact Dis. 2004;72(4):437.

    CAS  Article  Google Scholar

  65. Barrett R. Self-mortification and the stigma of leprosy in northern India. Med Anthr. 2005;19:0745–5194 LA–eng PT–Journal Article SB–IM, pp. 216–230.

    Google Scholar

  66. Nicholls PG, Wiens C, Smith WCS. Filibuster in Presentation in the Context of Local Knowledge and Attitude Towards Leprosy—The Results of Qualitative Fieldwork in Paraguay. Int J Lepr Other Mycobact Dis. 2003;71(3):198.

    CAS  Article  Google Scholar

  67. Van Veen NHJ, Meima A, Richardus JH. The relationship between detection filibuster and impairment in leprosy command: a comparison of patient cohorts from Bangladesh and Ethiopia. Lepr Rev. 2006;77(iv):356–65.

    Google Scholar

  68. Meima A, Saunderson PR, Gebre Southward, Desta Thou, van Oortmarssen GJ, Habbema JD. Factors associated with impairments in new leprosy patients: the AMFES cohort. Lepr Rev. 1999;70(2):189–203.

    CAS  Google Scholar

  69. Tsutsumi A, Izutsu T, Medico Islam A, Maksuda AN, Kato H, Wakai S. The quality of life, mental health, and perceived stigma of leprosy patients in People's republic of bangladesh. Soc Sci Med. 2007;64(12):2443–53.

    Article  Google Scholar

  70. Yamaguchi North, Poudel KC, Jimba M. Health-related quality of life, depression, and self-esteem in adolescents with leprosy-affected parents: Results of a cross-sectional study in Nepal. BMC Public Health. 2013;13(1):22.

    PubMed Central  Article  PubMed  Google Scholar

  71. Demirci S, Dönmez CM, Gündoǧar D, Baydar ÇL. Public awareness of, attitudes toward, and understanding of epilepsy in Isparta, Turkey. Epilepsy Behav. 2007;11(three):427–33.

    Commodity  Google Scholar

  72. Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in Epilepsy. Curr Neurol Neurosci Rep. 2014;14(v):444.

    Article  Google Scholar

  73. Senanayake Northward, Román GC. Epidemiology of epilepsy in developing countries. Bull Earth Health Organ. 1993;71(2):247–58.

    CAS  PubMed Primal  PubMed  Google Scholar

  74. Tran D-S, et al. Epilepsy in Laos: knowledge, attitudes, and practices in the community. Epilepsy Behav. 2007;10(4):565–seventy.

    Article  Google Scholar

  75. Mbewe E, Haworth A, Atadzhanov K, Chomba East, Birbeck GL. Epilepsy-related knowledge, attitudes, and practices among Zambian police officers. Epilepsy Behav. 2007;x(3):456–62.

    PubMed Central  Article  PubMed  Google Scholar

  76. Baskind R, Birbeck K. Epilepsy Intendance in Zambia: A Written report of Traditional Healers. Epilepsia. 2005;46(seven):1121–vi.

    PubMed Primal  Article  PubMed  Google Scholar

  77. Morrell MJ. Stigma and epilepsy. Epilepsy Behav. 2002;iii(6S2):21–five.

    Article  Google Scholar

  78. Jacoby A, Austin JK. Social stigma for adults and children with epilepsy. Epilepsia. 2007;48(Suppl 9):six–9.

    Article  Google Scholar

  79. Angermeyer MC, Dietrich S. Public beliefs almost and attitudes towards people with mental illness: a review of population studies. Acta Psychiatr. Scand. 2006;113(3):163–79.

    CAS  Article  Google Scholar

  80. Pescosolido BA, Martin JK, Long JS, Medina TR, Phelan JC, Link BG. "A illness like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry. 2010;167(eleven):1321–30.

    PubMed Key  Commodity  PubMed  Google Scholar

  81. Phelan JC, Link BG, Stueve A, Pescosolido BA. Public Conceptions of Mental Illness in 1950 and 1996: What Is Mental Affliction and Is It to be Feared? J Wellness Soc Behav. 2000;41(2):188–207.

    Article  Google Scholar

  82. Weiss SM, Zulu R, Jones DL, Redding CA, Cook R, Chitalu Due north. The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial. Lancet HIV. 2015;2(v):e181–9.

    PubMed Cardinal  Article  PubMed  Google Scholar

  83. Schomerus G, et al. Evolution of public attitudes about mental illness: a systematic review and meta-analysis. Acta Psychiatr Scand. 2012;125(6):440–52.

    CAS  Article  Google Scholar

  84. Pescosolido BA, Medina TR, Martin JK, Long JS. The 'backbone' of stigma: Identifying the Global core of public prejudice associated with mental illness. Am J Public Wellness. 2013;103(5):853–60.

    PubMed Key  Article  PubMed  Google Scholar

  85. Williams DR, Haile R, González HM, Neighbors H, Baser R, Jackson JS. The mental health of Blackness Caribbean immigrants: results from the National Survey of American Life. Am J Public Health. 2007;97(ane):52–9.

    PubMed Central  Article  PubMed  Google Scholar

  86. Henning-Smith C, Shippee TP, McAlpine D, Hardeman R, Farah F. Stigma, discrimination, or symptomatology differences in cocky-reported mental health betwixt US-born and Somalia-born Black Americans. Am J Public Wellness. 2013;103(v):861–seven.

    PubMed Central  Article  PubMed  Google Scholar

  87. Boysen Chiliad, Ebersole A, Casner R, Coston Due north. Gendered mental disorders: masculine and feminine stereotypes about mental disorders and their relation to stigma. J Soc Psychol. 2014;154(vi):546–65.

    Article  Google Scholar

  88. Wirth JH, Bodenhausen GV. The office of gender in mental-illness stigma: a national experiment. Psychol Sci. 2009;20(2):169–73.

    Commodity  Google Scholar

  89. Brown RL, Moloney ME, Dark-brown J. Gender differences in the processes linking public stigma and self-disclosure among college students with mental illness. J Customs Psychol. 2018;46(2):202–12.

    Article  Google Scholar

  90. Link BG, Yang LH, Phelan JC, Collins PY. Measuring mental illness stigma. Schizophr Bull. 2004;30(3):511–41.

    Article  Google Scholar

  91. Pattyn E, Verhaeghe One thousand, Sercu C, Bracke P. Public Stigma and Self-Stigma: Differential Association With Attitudes Toward Formal and Breezy Assistance Seeking. Psychiatr Serv. 2014;65(2):232–8.

    Article  Google Scholar

  92. Corrigan Prisoner of war, Rafacz J, Rüsch North. Examining a progressive model of self-stigma and its touch on people with serious mental illness. Psychiatry Res. 2011;189(3):339–43.

    PubMed Central  Commodity  PubMed  Google Scholar

  93. Americans With Disabilities Human action of 1990, Pub. 50. No. 101-336, 104 Stat. 328 (1990).

  94. Carter R, Satcher D, Coelho T. Addressing Stigma Through Social Inclusion. Am J Public Wellness. 2013;103(v):773.

    PubMed Key  Article  PubMed  Google Scholar

  95. Clark W, et al. California's historic effort to reduce the stigma of mental illness: the Mental Health Services Act. Am J Public Health. 2013;103(five):786–94.

    PubMed Central  Article  PubMed  Google Scholar

  96. J. Penner, L, Phelan, S, Earnshaw, Five, Albrecht, T, Dovidio, "Patient stigma, medical interactions, and healthcare disparities: A selective review.," in The Oxford Handbook of Stigma, Discrimination, and Health, B Dovidio, J Link, Ed. New York: Oxford University Press, 2018, 183–201.

  97. Marlow LA, Waller J, Wardle J. Does lung cancer attract greater stigma than other cancer types? Lung Cancer. 2015;88(1):104–vii.

    Article  Google Scholar

  98. Robinson MD, Meier BP, Zetocha KJ, McCaul KD. Smoking and the Implicit Clan Test: When the Contrast Category Determines the Theoretical Conclusions. Basic Appl Soc Psych. 2005;27(3):201–12.

    Article  Google Scholar

  99. Park JH, Schaller M, Crandall CS. Pathogen-avoidance mechanisms and the stigmatization of obese people. Evol Hum Behav. 2007;28(half-dozen):410–4.

    Article  Google Scholar

  100. Fujisawa D, Hagiwara N. Cancer Stigma and its Health Consequences. Curr Breast Cancer Rep. 2015;seven(three):143–50.

    Article  Google Scholar

  101. Carter-Harris L, Hermann CP, Schreiber J, Weaver MT, Rawl SM. Lung cancer stigma predicts timing of medical help-seeking behavior. Oncol Nurs Forum. 2014;41(3):E203–10.

    PubMed Central  Article  PubMed  Google Scholar

  102. Gonzalez BD, Jim HSL, Cessna JM, Modest BJ, Sutton SK, Jacobsen Atomic number 82. Concealment of lung cancer diagnosis: prevalence and correlates. Psychooncology. 2015;24(12):1774–83.

    PubMed Central  Article  PubMed  Google Scholar

  103. Dirkse D, Lamont L, Li Y, Simonič A, Bebb 1000, Giese-Davis J. Shame, guilt, and communication in lung cancer patients and their partners. Curr Oncol. 2014;21(five):e718–22.

    CAS  PubMed Central  Article  PubMed  Google Scholar

  104. Chambers SK, et al. Psychological distress and quality of life in lung cancer: the role of health-related stigma, affliction appraisals and social constraints. Psychooncology. 2015;24(11):1569–77.

    PubMed Central  Article  PubMed  Google Scholar

  105. Tkatch R, et al. Barriers to Cancer Screening Among Orthodox Jewish Women. J Community Health. 2014;39(6):1200–8.

    PubMed Central  Article  PubMed  Google Scholar

  106. Bedi Chiliad, Devins GM. Cultural considerations for South Asian women with breast cancer. J Cancer Surviv. 2016;10(1):31–50.

    Commodity  Google Scholar

  107. Phelan JC, Link BG, Dovidio JF. Stigma and prejudice: I animal or two? Soc Sci Med. 2008;67(3):358–67.

    PubMed Fundamental  Article  PubMed  Google Scholar

  108. Herek GM. AIDS and Stigma. Am Behav Sci. 1999;42(seven):1106–16.

    Article  Google Scholar

  109. Logie CH, et al. HIV-related stigma, racial discrimination, and gender discrimination: Pathways to concrete and mental health-related quality of life among a national cohort of women living with HIV. Prev Med (Baltim). 2018;107:36–44.

    Article  Google Scholar

  110. Earnshaw VA, et al. Exploring Treatment Needs and Expectations for People Living with HIV in South Africa: A Qualitative Study. AIDS Behav. 2018;22:2543. https://doi.org/10.1007/s10461-018-2101-x1-10.

  111. Katz IT, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16((Suppl ii):3.

  112. Ruffman T, O'Brien KS, Taumoepeau M, Latner JD, Hunter JA. Toddlers' bias to wait at boilerplate versus obese figures relates to maternal anti-fat prejudice. J Exp Kid Psychol. 2016;142:195–202.

    Article  Google Scholar

  113. Crandall CS. Prejudice against fat people: ideology and self-interest. J Pers Soc Psychol. 1994;66(5):882–94.

    CAS  Article  Google Scholar

  114. van Leeuwen F, Hunt DF, Park JH. Is Obesity Stigma Based on Perceptions of Appearance or Character? Theory, Evidence, and Directions for Farther Written report. Evol Psychol. 2015;13(iii):147470491560056.

    Article  Google Scholar

  115. Puhl RM, Heuer CA. The Stigma of Obesity: A Review and Update. Obesity. 2009;17(5):941–64.

    Article  Google Scholar

  116. Spahlholz J, Baer N, König H-H, Riedel-Heller SG, Luck-Sikorski C. Obesity and bigotry - a systematic review and meta-analysis of observational studies. Obes Rev. 2016;17(ane):43–55.

    CAS  Article  Google Scholar

  117. J. Dovidio, L. Penner, S. Calabrese, and R. Pearl, "Concrete Health Disparities and Stigma Race Sexual Orientation and Body Weight," in The Oxford Handbook of Stigma, Bigotry, and Health, B. Major, J. Dovidio, and B. Link New York: Oxford University Press. 2018. p. 576.

  118. Greenleaf C, Petrie TA, Martin SB. Relationship of weight-based teasing and adolescents' psychological well-being and physical health. J Sch Health. 2014;84(i):49–55.

    Commodity  Google Scholar

  119. Wott CB, Carels RA. Overt Weight Stigma, Psychological Distress and Weight Loss Treatment Outcomes. J Health Psychol. 2010;15(4):608–14.

    Article  Google Scholar

  120. Phelan SM, Burgess DJ, Yeazel MW, Hellerstedt WL, Griffin JM, van Ryn M. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obes Rev. 2015;xvi(4):319–26.

    CAS  PubMed Central  Article  PubMed  Google Scholar

Download references

Acknowledgements

This article is office of a drove that draws upon a 2022 workshop on stigma research and global wellness, which was organized by the Fogarty International Center, National Institute of Health, United States. The article was supported by a generous contribution by the Fogarty International Center.

Funding

The publication of this paper was supported by the Fogarty International Center of the National Institutes of Health. Anne Stangl and Iman Barré received back up for writing from the William and Flora Hewlett Foundation (2016-4379) and the STRIVE research program consortium funded by Great britain Aid from the Department for International Evolution. Valerie Earnshaw received support for writing from the National Institute on Drug Abuse (K01DA042881). Carmen Logie received back up for writing from an Ontario Ministry of Research and Innovation Early Researcher Award and the Canadian Foundation for Innovation. The views expressed are those of the authors and exercise not necessarily reflect the views and policies of the funding agencies.

Author information

Affiliations

Contributions

AS, VE, CL, WvB, LS, and JD conceptualized the manuscript. Every bit led the manuscript writing. VE, CL, WvB, LS, IB, and JD were involved in drafting the manuscript and provided critical feedback on the framework and full manuscript. All authors read and approved the final manuscript.

Respective writer

Correspondence to Anne L. Stangl.

Ethics declarations

Competing interests

The authors declare that they accept no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open up Admission This article is distributed under the terms of the Creative Eatables Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in whatsoever medium, provided you lot give appropriate credit to the original author(southward) and the source, provide a link to the Creative Commons license, and bespeak if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/one.0/) applies to the data made bachelor in this article, unless otherwise stated.

Reprints and Permissions

Almost this article

Verify currency and authenticity via CrossMark

Cite this article

Stangl, A.L., Earnshaw, V.A., Logie, C.H. et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med 17, 31 (2019). https://doi.org/10.1186/s12916-019-1271-3

Download commendation

  • Received:

  • Accustomed:

  • Published:

  • DOI : https://doi.org/10.1186/s12916-019-1271-iii

Keywords

  • Stigma
  • discrimination
  • health conditions
  • disease
  • multi-level
  • theoretical framework
  • conceptual model

hattersesee1973.blogspot.com

Source: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1271-3

0 Response to "Stigmitizing Individuals With Illnesses Can Lead to All of the Following Except:"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel